CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer
CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer have?
CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer has 211 citations in the OpenAlex counts ScholarIQ stores.
When was CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer published?
CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer has 2011 year in the ScholarIQ index.
What is the open-access status of CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer?
CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer has bronze oa status in the ScholarIQ index.
What is the DOI of CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer?
The DOI for CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer is on the source record.
What is the PMID of CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer?
The PMID for CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer is on the source record.
What is the OpenAlex record for CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer?
The OpenAlex for CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer is on the source record.